🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension

RecruitingNAAges 18 Years - anyAllUniversity of Sao Paulo General Hospital
NCT07120789 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This methodological study aims to develop and validate a questionnaire named for the Assessment of Patient Knowledge in Pulmonary Arterial Hypertension. The study will be conducted in four phases: (1) questionnaire development based on guidelines and literature; (2) content validation by expert judges; (3) semantic validation with patients; and (4) psychometric testing in a sample of up to 200 patients with confirmed pulmonary arterial hypertension (PAH). In addition to validation, the study will collect clinical and functional data from medical records, including risk stratification using the COMPERA 2.0 method The final instrument is expected to support patient education strategies and contribute to improved clinical management of PAH.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years or older * Confirmed diagnosis of Group 1 Pulmonary Arterial Hypertension (PAH) * Ability to read and understand the questionnaire language * Provided informed consent to participate in the study * For expert judges (content validation phase): professionals with recognized expertise in pulmonary hypertension, with academic or clinical experience in the field Exclusion Criteria: * Cognitive, visual, or auditory impairments that hinder questionnaire comprehension * Refusal to participate or withdrawal of informed consent * Inability to complete the questionnaire due to clinical instability
💊

What it tests

  • Application of Patient Knowledge Questionnaire on Pulmonary Hypertension
📍

Where

1 site
Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo
São Paulo, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy